32 matches.

  • Blogs
    OIG Advisory Opinion 26-14 Offers Another Favorable Path for Patient Access Through Sponsored Testing
    Clock 12 minute read
  • Firm Announcements
    65 Epstein Becker Green Attorneys, 20 Practice Categories Recognized by Chambers USA for Delivering Excellence on Behalf of Clients in 2026
    Clock 6 minute read
  • Firm Announcements
    Life Sciences Regulatory Attorney Alison Fethke Joins Epstein Becker Green, Strengthening Firm's FDA and Compliance Capabilities
    Clock 3 minute read
  • Media Coverage
    Media Covers Alison Fethke’s Move to Epstein Becker Green
    Clock 4 minute read
  • Events
    Patient Assistance and Access Programs (PAP) 2026 Conference: Legal Address—Stay on the Pulse of Regulatory Changes
  • Events
    26th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress: Patient-Oriented Commercial Models - Legal and Market Access Considerations
  • Events
    Medicaid Drug Rebate Program Summit: Direct to Consumer Commercialization Models Market Access Considerations
  • Events
    25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress: Exploring Risks and Enforcement Trends for Buy-and-Bill Drugs
  • Publications
    Feds' Biotech Enforcement Efforts Are Too Heavy-Handed, Law360
  • Events
    24th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress: Alternative Funding Vendors - the Future and Options for Responding to New Challenges to Patient Support Programs
  • Publications
    OIG Finds Physician-Owned Medical Device Innovator Not a Suspect "POD," Westlaw Today
  • Events
    Virtual 22nd Annual Pharmaceutical and Medical Device Ethics and Compliance Congress: How to Establish Risk Tolerance in an Emerging Organization
  • Events
    Pharmaceutical Compliance Congress: High-Risk Areas Related to Patient Assistance and Support Programs
  • Events
    Drug Pricing 2021: An Overview and the Evolving Legal and Policy Landscape
  • Publications
    Compliance Considerations for Pharma Co. Testing Programs, Law360
  • Events
    Charitable Patient Assistance Programs: Ensuring Compliance
  • Events
    A&M Healthcare Industry Group: Part II, Telehealth—Addressing Necessary Regulatory and Compliance Risk
  • Events
    PAP 2020, 21st Annual Patient Assistance & Access Programs: Emerging Best Practices and Industry Trends in Free Drug Programs
    August 3–7, 2020
  • Events
    IPMI Healthcare General Counsel Forum: Optimizing Your Compliance, Privacy & Security, and Quality Programs
  • Events
    20th Annual Pharmaceutical and Medical Device Compliance Congress: Medical Affairs Proactive Communications, Engagement by Manufacturers
  • Events
    19th Annual Pharmaceutical and Medical Device Compliance Congress: Mini Summit 19: "All in Compliance"—Aligning with Your Business Partners
    November 7–9, 2018
  • Publications
    Distributors Expose Health, Life Science Companies to FCPA Risks, Law360
  • Events
    Seventh Annual Patient Advocacy Engagement Conference: Roundtable Discussion—Anti-Kickback Constraints on Compensating Patients
  • Events
    3rd Annual Life Science Compliance Training Conference: Current Areas of Concern for Life Science Corporations—Foreign Corrupt Practices Act
    June 6–7, 2018
  • Publications
    Emerging Enforcement Trends for Patient Support Programs, Law360
  • Publications
    Risky Business for Pharma, Pharmaceutical Market Europe
  • Events
    Pharmaceutical and Medical Device Compliance Congress: Global Compliance in the Transactional Context—Due Diligence, Integration, and Post-Transaction Steps
    November 6–8, 2017
  • Publications
    How Conduct Abroad Impacts Health Care Business in US, Law360
  • Publications
    Value-Based Challenges and Opportunities for Pharma Cos., Law360
  • Publications
    Featured: Helping Piece Together the Life Sciences Puzzle, Chicago Daily Law Bulletin
  • Events
    Pharmaceutical Regulatory and Compliance Congress: Compliance Considerations in Patient Support Programs
    November 3–5, 2014
  • Publications
    Unknowing Company Executives Held Responsible for FDCA Violations, Inside Counsel

Filters

Clear
Jump to Page
Advanced Search ›

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.